We are excited to announce our groundbreaking new partnership with CareDx to develop and commercialize AlloID, a powerful infectious disease detection tool that identifies 100+ pathogens and drug resistance in viruses and bacteria critical to organ transplant patients.
Experience an interactive introduction to the Explify® Platform where you’ll learn about advancements in clinical metagenomics and the nuances behind the many testing options available in today’s laboratory testing environment.
For Research Use Only. Not for use in diagnostic procedures.
We are proud to collaborate with Illumina and offer the new Respiratory Pathogen ID/AMR Panel (RPIP), which provides comprehensive detection of 200+ respiratory pathogens and 1,245 antimicrobial resistance genes.
Watch our new Explify Enrichment video about how it’s now possible to perform comprehensive pathogen detection and quantification as well as identify hundreds of genetic markers of antibiotic resistance within a 24-hour turnaround time.
IDbyDNA is supporting two new CME programs offered by Medscape: “A Clinician’s Guide to Making Sense of Metagenomics” and “From Principles to Practice: How Can Metagenomics Inform Patient Care?”
Clinical metagenomics enables culture-free, hypothesis-free detection of uropathogens and genetic markers of antibiotic resistance. By coupling the power of lllumina's next-generation sequencing and IDbyDNA's Explify analytics, a streamlined specimen-to-report shotgun workflow can be performed in 24 hours.